(Total Views: 202)
Posted On: 06/16/2023 10:00:51 AM
Post# of 38

$VTVT News Article - vTv Therapeutics Partner Cantex Pharmaceuticals Licenses Exclusive Rights to Intellectual Property from Georgetown University for Azeliragon as a Potential Treatment for Cancer-Related Cognitive Decline https://marketwirenews.com/news-releases/vtv-...33443.html


My Twitter: WhyteStocks